Status:
UNKNOWN
Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Conditions:
End Stage Liver Disease
Acute Liver Failure
Eligibility:
All Genders
1-75 years
Brief Summary
This will be a study to examine the outcomes of open, laparoscopic, and robotic Living Donor Liver Transplantation (LDLT) procedures. The analysis will encompass 3,448 cases (1,724 donor-recipient pai...
Detailed Description
Background: Liver transplantation is a primary treatment for end-stage liver disease, enhancing survival rates and life quality. Living donor liver transplantation (LDLT) has gained prominence due to ...
Eligibility Criteria
Inclusion
- All donor and recipient pairs that underwent LDLT at the study institution
- Between 01 January 2011 to 31 March 2023
- Both adult-to-adult and adult-to-pediatric LDLT are included.
Exclusion
- Dual and domino LDLT are excluded.
Key Trial Info
Start Date :
August 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2023
Estimated Enrollment :
3448 Patients enrolled
Trial Details
Trial ID
NCT06062706
Start Date
August 6 2023
End Date
October 30 2023
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Centre
Riyadh, Saudi Arabia, 11563